MIST
Milestone Pharmaceuticals Inc
NASDAQ: MIST · HEALTHCARE · BIOTECHNOLOGY
$1.80
-1.10% today
Updated 2026-04-30
Market cap
$218.86M
P/E ratio
—
P/S ratio
141.57x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Milestone Pharmaceuticals Inc (MIST) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,116.00%
ROE
-229.60%
ROA
-41.10%
Debt/equity
2.79x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-8.09M | — | — | — |
| 2018 | $0.00 | $-23.18M | — | — | — |
| 2019 | $0.00 | $-55.23M | — | — | — |
| 2020 | $15.00M | $-49.97M | -2.51% | -338.07% | -333.11% |
| 2021 | $15.00M | $-42.85M | 100.00% | -287.15% | -285.69% |
| 2022 | $5.00M | $-57.13M | 100.00% | -1,192.84% | -1,142.68% |
| 2023 | $1.00M | $-59.69M | 100.00% | -6,109.80% | -5,968.50% |
| 2024 | $0.00 | $-41.52M | — | — | — |
| 2025 | $1.55M | $-63.06M | 92.63% | -4,041.72% | -4,078.78% |